GlassScriptPhysician profile
Ravi K Ved
NPI 1073956397
$1,008.94
in general payments reported to CMS, 2019-2025
7 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $209 · 2021: $223 · 2022: $125 · 2023: $25.25 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $296.63 | 2019-2025 | Euflexxa |
| Horizon Therapeutics Plc | $253.64 | 2020-2022 | |
| Bioventus LLC | $205.94 | 2019-2025 | Xcell |
| Electronic Waveform Lab, INC. | $121.55 | 2019-2022 | |
| Pacira Therapeutics, INC. | $89.50 | 2019-2020 | |
| Relievant Medsystems, INC. | $25.25 | 2023 | Intracept |
| Si-Bone, INC. | $16.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Ved listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.